Central Bank: Novartis Risks Not Getting Takeover Permission
Ljubljana, 19 September - Swiss pharmaceutical company Novartis is risking not getting permission to acquire Slovenian drug-maker Lek by wanting to pay the takeover in euros rather than in local currency, the vice-governor of Slovenia's central bank Darko Bohnec told the press on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 1.455 characters (without spaces) or 307 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.